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ABSTRACT 
This study compared health-related quality of life (QOL) and psychological morbidity 
in a population-based sample of first generation immigrant and Anglo-Australian 
cancer survivors. Eligible participants, recruited via three State Cancer Registries, 
included those: with a new diagnosis of one of 12 most incident cancers (all stages) 
1–6 years earlier; aged 18 - 80 at diagnosis; born in a Chinese, Arabic, or Greek 
speaking country and able to speak one of these languages. A random sample of 
English-speaking Anglo-Australian-born controls frequency matched for cancer 
diagnosis was recruited. 596 patients (277 of whom were immigrants) participated (a 
26% response rate). In multiple linear regression models adjusted for age, sex, 
education, marital status, socio-economic status, time since diagnosis and type of 
cancer, immigrants had clinically significantly worse QOL (5·4 to 8·5 points on 
FACT-G, P<0·0001), higher depression (P<0·0001), and higher incidence of clinical 
depression (P<0·01) than Anglo-Australians. Understanding the health system 
partially mediated this relationship for depression (P=0·0004) and QOL (P=0·001). 
Immigrant survivors of cancer have worse psychological and QOL outcomes than 
Anglo-Australians. Potential targets for intervention include assistance in navigating 
the health system, translated information, and cultural competency training for health 
professionals.  
 
Key words: health disparities, quality of life, anxiety, depression, immigrants, cancer, 
CALD, multi-culturalism, cultural competence, NESB 
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Global migration has led to growing ethnic and cultural diversity in developed 
countries. In 2005, Western and Central Europe hosted 44.1 million migrants,1 many of 
whom came from non-western countries, seeking social security, employment opportunities 
and a better future.2 
Disparities in cancer incidence and survival between ethnic minority and majority 
groups have been widely reported.2-4 While poorly understood,5 such disparities may 
be due to patient factors, including familiarity with the health system, language 
proficiency, culturally determined beliefs and behaviors and socio-economic status; 
health care provider factors such as discrimination and cultural competence; and 
structural barriers in health systems.6  
 
Immigrants are more vulnerable to psychiatric disorder and distress than the general 
population even when not ill,7 and this is likely true also of cancer survivors. In a 
recent meta-analysis,8  worse distress and quality of life (QOL) in minority Hispanic 
versus majority cancer patients in the US were reported. Evidence for disparity in 
other minority groups was poor. In most studies minority status was poorly defined, 
socio-demographic and health system factors were not well controlled for, and overall 
study quality was poor.  
 
The aims of the current study were to compare prevalence and severity of anxiety and 
depression and QOL in a population-based sample of first generation immigrant 
Australian cancer survivors and Anglo-Australian-born controls. We aimed to explore 
the contribution of immigrant-related variables such as understanding of the health 
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system to these outcomes. We restricted the immigrant sample to Chinese, Arabic or 
Greek speakers, who represent the largest Australian immigrant groups.  
 
 
METHODS 
 
Participants 
Participants were recruited via Cancer Registries in three states: NSW, Queensland, 
and Victoria. By law, all cancer diagnoses are reported to state-based cancer registries. 
Eligible survivors had been diagnosed with a new histologically confirmed cancer 
comprising one of the top 12 most common cancers (all stages) 1 to 6 years earlier, 
were aged between 18 and 80 years at the time of diagnosis, and had a treating doctor 
assigned to their registry record.  
 
Eligible immigrant participants were born in, and had parents born in, a country 
where Chinese (Mandarin, Cantonese, and other dialects), Arabic, or Greek is spoken, 
had a family name indicative of this cultural background, and were subsequently 
confirmed to speak one of these languages. A random sample of Australian-born 
participants was selected from the same cancer registries in proportions matching the 
distribution of cancer types amongst immigrant survivors, and subsequently 
confirmed to have both parents born in a country where English is the primary 
language.  
 
This study was approved by relevant ethical review boards.  
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Procedure 
We established a community advisory group for each language group comprising 
consumers, health care professionals, and community leaders who reviewed study 
procedures and materials and provided advice regarding recruitment and 
interpretation of results.  
 
Translation of measures proceeded according to the European Organization for 
Research and Treatment of Cancer translation protocol.9 All measures not already 
available and validated in the required languages were translated by National 
Accreditation Authority for Translators and Interpreters accredited translators 
experienced in health terminology, and were back-translated by an independent 
translator. Discrepancies were discussed and resolved. Questionnaires were field 
tested as recommended by Schuman10 and revised.  
 
Figure 1summarizes participant flow. Registries sought confirmation from each 
potentially eligible survivor’s referring doctor that they were eligible for the study and 
aware of their diagnosis. Registries then contacted survivors to request consent for 
researcher contact, and confirmation that they and their parents were born in a country 
where Chinese, Arabic, Greek or English was spoken and spoke this language. Those 
who did not initially respond were sent one reminder. Interested survivors were 
invited to participate by phone and/or mail by bilingual researchers. Survivors were 
mailed study packages comprising a cover letter, questionnaire, information sheet, 
consent form, and reply paid envelope. Non-responders were followed up by phone 
(four attempts), and then by one mailing.  
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<Figure 1 about here> 
 
Measures 
Demographic and clinical details were obtained from the cancer registry, including 
age at diagnosis, date of diagnosis, primary cancer type, disease extent of disease at 
diagnosis, and measures of rurality and socio-economic status based on postcode at 
diagnosis. Other patient-elicited demographic details were years lived in Australia, 
marital and employment status, religion, education level, confidence speaking and 
understanding English, and understanding of the health system.  
 
Primary outcomes 
Anxiety and depression were assessed using the Hospital Anxiety and Depression 
Scale (HADS)11, comprising 14 items, 7 measuring anxiety and 7 depression, already 
translated and validated in Chinese, Arabic, and Greek.12,13. Validity of subscale 
scores are demonstrated by high correlation with psychiatric ratings.11 Scores above 
10 out of a possible 28 are considered indicative of clinical morbidity.  
 
Quality of life was assessed using the Functional Assessment of Cancer Therapy – 
General. The FACT-G14 is a 27 item, widely used measure of cancer QOL with high 
reliability and validity, assessing physical, emotional, social, and functional well-
being with higher scores reflecting better QOL (possible range 0-100).The FACT-G is 
available in Chinese, Greek and Arabic.15,16 
 
 
Covariates and potential confounders 
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Variables assessed for confounding were: age, gender, SES (continuously, as the 
IRSAD score (index of relative social advantage and disadvantage17)), education (low, 
medium, high), marital or partnered status (yes or no), major city versus 
regional/remote residence, religion, time since diagnosis, cancer type (colorectal, 
breast, leukaemia and lymphoma, bladder and kidney, head and neck and other), 
currently on treatment (yes or no), extent of disease (localized, regional spread or 
distant metastases). Cancer type was categorized according to most incident cancer 
diagnoses, with less common cancers grouped into an ‘other’ category.  
 
Immigrant factors 
Variables explored in immigrant only models included years in Australia, English 
language ability, and difficulty understanding the health care system. The latter was 
measured using a study-developed single item asking participants to rate their 
understanding of the Australian health care system on a 4 point scale, which was then 
dichotomized (‘very well’ and ‘well’ versus ‘not so well’ and ‘not well at all’) and 
used in mediation models.  
 
Statistical Methods 
Chi-squared and t-tests were used to compare immigrants and Anglo-Australians on 
demographic and disease variables. QOL, anxiety, and depression were compared 
between groups in unadjusted and adjusted linear regressions. The pre-specified 
adjusted models included: language group, age, gender, SES, education, 
marital/partnered status, time since diagnosis and cancer type, on the basis of 
observed differences between groups and theoretical importance. The linearity of 
continuous predictor variables was inspected using fractional polynomials,18 and if no 
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substantial non-linearity was present, were used linearly. To investigate whether these 
differed between immigrants and Anglo-Australians we used interaction terms.  
 
Immigrant variables were used in pre-specified multiple linear regression models as 
predictors of anxiety, depression and QOL among the three language groups only (not 
including Anglo-Australians). These models also included age, sex, education, 
married, SES, time since diagnosis, and type of cancer. 
 
We tested whether difficulties understanding the health care system mediated the 
effect of immigrant status (as a binary variable) and each of the outcomes by using the 
Sobel test19 and Baron and Kenney’s methods.20  
Sensitivity analyses 
Our registry-reported measure of  extent of disease had a 20% rate of 
missing/unknown/not appropriate. However, in the remaining data, only 16 patients 
(3%) were coded as distant metastases, and according to patient self-report, 87% had 
cancer which had gone away, 6% reported their cancer had come back, and 6% that it 
had spread. Because of the missing data rate, and the very few patients coded as 
advanced stage in existing data, we did not include extent of disease in the adjusted 
models. However, we performed additional analyses to check the sensitivity of our 
primary results to different assumptions about stage. These included: 1) using the 
registry extent of disease variable; 2) using the patient reported extent of disease 
variable; 3) restricting the sample to those without missing registry extent of disease; 
and 4) assigning, proportionally, those with missing registry extent of disease to the 
other categories.  
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RESULTS 
 
Participants 
There were 4369 potentially eligible cancer survivors identified, comprising 2842 
immigrants and 1527 Anglo-Australians. Figure 1 summarizes recruitment.  
 
Of these 4369, 2307 were confirmed to be eligible by their physicians and contacted 
by the registry. A total of 693 survivors agreed to be contacted and were invited to 
participate in the study. Of these, 596 returned a survey, yielding an overall response 
rate of 26%. 
 
Non-responders were defined as those who declined or did not respond to the 
registry’s approach, as well as those who consented to researcher contact, but then 
declined or did not respond to the invitation to participate. Clinical and demographic 
characteristics were similar between participants and non-responders, as shown in 
Table 1.  
 
Table 2 shows demographic and clinical details for study participants. There were no 
statistically significant differences between Anglo-Australians and immigrants for sex, 
religion, marital status, currently on treatment, cancer type and extent of disease, age, 
and time since diagnosis. A significantly higher proportion of immigrants were in 
both the low and highly educated groups. Significantly more Anglo-Australians lived 
in regional/remote areas than immigrants (but the vast majority lived in major cities. 
Comparatively more immigrants fell in the higher socioeconomic status category 
(29% versus 18%).  
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Differences between groups in QOL and psychological morbidity 
Compared with Anglo-Australians, immigrants had higher levels of depression (P 
<0·0001) and lower levels of QOL (P <0·0001), as shown in Table 3. Arabic 
participants had the highest levels of depression, as well as the lowest QOL. The 
minimal important difference (MID) for QOL using the FACT-G has been estimated 
as being between 3 and 721; our estimated differences between Anglo-Australians and 
Arabic immigrants was 8·5, for Chinese  5·4, and for Greek 5·8. Greek and Arabic 
patients had elevated anxiety. Notably, the significant differences observed in QOL 
and depression are between immigrants and Anglo-Australians, with little difference 
between individual immigrant groups on these outcomes.  
 
The estimated prevalence of clinical depression was 11% for Arabic participants, 9% 
for Chinese, 9% for Greek and 2% for Anglo-Australian (𝜒32=15·7, P=0·001). The 
estimated prevalence of clinical anxiety was 12% for Arabic participants, 6% for 
Chinese, 13% for Greek and 9% for Anglo-Australian (𝜒32=3.1, P=0·4).  
  
Predictors of anxiety and depression and QOL 
In models that included all participants, the only variable other than immigrant status 
which was statistically significant was age for anxiety (p<0·0001). Anxiety decreased 
with age by 0·7 points per 10 years (95% CI: 0·4, 1·0). We found no statistically 
significant interactions between immigrant status and any of the candidate covariates.  
 
Sensitivity analyses for extent of disease 
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We found that estimates of differences between Anglo-Australians and immigrants in 
anxiety, depression and QOL, and associated p-values, did not change substantively 
according to the four sensitivity analyses using different estimates of extent of disease.  
 
Mediation  
Understanding the health system partially mediated the relationship between 
immigrant status (immigrant versus Anglo-Australian) and depression (P=0·0004) 
and QOL (P=0·001). The indirect effect of understanding the health system accounted 
for 55% of the total effect for depression and 25% for QOL. This implies, for example, 
that about half of the effect of immigrant status on depression is explained by whether 
or not the participant understands the health system.  
 
Immigrant-specific variables 
Table 4 shows the results of analyses investigating which variables are associated 
with anxiety, depression and QOL for immigrants only. Understanding the health 
system was associated with lower values of depression (P=0·02). Marginally 
statistically significant associations with QOL included education and confidence 
understanding English, with participants with medium levels of education having 
lower levels of QOL (P=0·05); and those with confidence understanding English 
having higher QOL by an estimated 5·0 points (P=0·06). These models explained 
13·6%, 7·2% and 9·0% of the variance (R2) for anxiety, depression and QOL 
respectively. 
 
DISCUSSION 
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This large, population-based study has shown that even when controlling for potential 
demographic and disease confounders, immigrants with cancer in the post-treatment 
survivorship phase have clinically significantly worse quality of life (QOL) and 
higher reported depression than Anglo-Australian-born cancer survivors matched on 
cancer diagnosis. Further, a significant proportion of immigrant participants were 
experiencing clinical levels of depression (11% of Arabic, 9% of Chinese, 9% of 
Greek versus only 2% of Anglo-Australians), despite being on average 3 years since 
diagnosis with primarily early stage cancer.  
 
Our findings corroborate findings from our meta-analysis of previous studies 
(primarily of Hispanics in US) reporting disparities in cancer patient reported 
outcomes in minority versus majority populations.8 This suggests that such disparities 
are present not only in Hispanic Americans, but also in other ethnic groups 
immigrating to other countries. Thus this is an issue likely to have international 
significance, requiring a widespread response.  
 
Unlike most previous studies, our sample was sufficiently large to allow sub-group 
analyses of outcomes for different ethnic groups. While Arabic cancer patients 
reported the highest depression and worst QOL, the differences between ethnic 
groups were not significant. This suggests it is immigrancy/minority status itself, 
rather than cultural factors that make adjustment after cancer more difficult. Further, 
understanding of the health system, education and difficulty understanding English 
mediated outcomes in immigrants, while average years in Australia (45 years for 
Greeks versus 24 and 27 for Chinese and Arabic participants), did not, suggesting that 
more than time is required for acculturation and adjustment.  
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Our data suggest the need for interventions to address the factors underlying 
disparities. Navigating the health system in a new country where health practices, role 
expectations and health services are different from those of the home country is 
challenging, particularly with a disease like cancer, where multiple health 
professionals are involved. Native-born cancer patients find it difficult to know how 
to access services or who to contact for information or support22, so it is not surprising 
that immigrants find this particularly challenging.  
 
In our sample 32% of immigrants reported they had poor understanding of English. In 
a previous qualitative study with immigrants with cancer, immigrants reported a sense 
of cultural estrangement from health professionals and difficulty understanding 
English.23 Interpreters, while addressing some of these issues, do not always help and 
sometimes hinder.24,25  
 
In a review of studies evaluating interventions specifically for immigrants with cancer, 
we found few studies, many of which had methodological deficiencies; some 
specifically excluded non-English speakers. Patient navigation interventions appear 
promising for reducing delays before diagnosis,26 and improving treatment 
adherence.27,28,29 Only two trials targeted emotional well-being, both demonstrating 
efficacy in Hispanic populations.30-32 There remains a need to evaluate interventions 
outside the Hispanic population to reduce depression and improve QOL in immigrants 
with cancer.  
 
 15 
We aimed to conduct a population-based study and therefore recruited through cancer 
registries which capture data on all cancers diagnosed. Despite assiduous attention to 
study processes and extensive follow-up, our final response rate was low, although 
similar to other studies with immigrant and minority populations.33 As approach 
protocols were designated by registries, there was little we could do to tailor 
approaches to maximize recruitment. Once potential participants reached our bi-
lingual researchers, consent rates were high. Despite the response rate, differences 
between respondents and non-respondents in key demographic and clinical variables 
were minimal, promoting confidence that the results are representative of the source 
populations. We were restricted by feasibility issues to including cancer survivors 
only from Chinese, Arabic and Greek speaking countries. Thus our results may not 
generalize to other immigrant groups.  
 
Our study has explored potential challenges but not potential strengths of immigrant 
groups. Stephens and colleagues34 noted a positive relation between low acculturation 
and life satisfaction among US Hispanic patients, due to strong social support and 
spirituality. Thus in some groups, adjustment may be enhanced by internal 
community strengths.  
 
This is the largest study internationally to explore differences between immigrant and 
native-born cancer survivors, controlling for potential confounders and exploring 
immigrant-specific contributors to poorer outcomes. Future research needs to address 
cancer patients’ reported outcomes during the active treatment phase, to explore 
strengths as well as challenges of immigrancy, and to evaluate interventions to reduce 
disparities. Recently, Rechel et al35 surveyed European cancer registries regarding 
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current data collection systems in the European Union (EU) that allow the monitoring 
of migrant health. They found that registry data on health care utilization by migrant 
status was available in only 11 of 27 member states and that few countries collect 
large-scale survey data on migrant health and health care utilization. They concluded 
that there is an urgent need for EU countries to step up their organizational and 
regulatory efforts to monitor migrant health, and to adopt a common definition and 
method for identifying migrants. Such developments would allow the 
recommendations of this paper to be enacted.  
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Figure 1 – Recruitment outcomes 
 
Potentially eligible survivors per registry records   (n = 4369) Immigrant = 2842;  Anglo-Australian = 1527 ELIGIBILITY NOT CONFIRMED  BY TREATING DOCTOR   (n = 1972)   UNABLE TO CONTACT SURVIVOR        (n = 90) Survivor eligibility confirmed by GP/ treating physician, and contacted by registry (n = 2307) Immigrant = 1499;  Anglo-Australian = 808  NO CONSENT TO RELEASE DETAILS  TO RESEARCH TEAM   (n = 1584) Did not respond                    (n = 1250) Declined                       (n = 334)  INELIGIBLE PARENTAL COUNTRY OF BIRTH (n = 25) MOVED OVERSEAS                       (n = 5)  Consented to researcher approach  (n = 693) Immigrant = 327;  Anglo-Australian = 366  NOT RECRUITED   (n = 97) Did not respond   (n = 44) Declined   (n = 53) 
Returned questionnaire (n = 596)* Immigrant = 277;  Anglo-Australian = 319 
RR = 86% 
(26% of survivors 
contacted by registry)  
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Table 1. Demographic and clinical characteristics for responders vs. non-responders 
Characteristic Participants 
N = 596 
Non-respondents 
N = 1683 
 n (%) n (%) 
Gender   
Male 306 (51) 819 (49) 
Female 290 (49) 864 (51) 
Cancer type   
Breast 204 (34) 563 (33) 
Prostate 154 (26) 377 (22) 
Colorectal 105 (18) 355 (21) 
Bladder, kidney 42 (7) 143 (8) 
Leukaemia, lymphomas 45 (8) 99 (6) 
Head and neck 25 (4) 68 (4) 
Other  21 (4) 78 (5) 
State   
New South Wales 276 (46) 721 (43) 
Victoria 277 (46) 884 (53) 
Queensland 43 (7) 78 (5) 
Residencea   
Major city 545 (93) 1424 (85) 
Regional and remote 40 (7) 181 (11) 
Extent of disease at diagnosisa    
Localized  342 (57) 883 (52) 
Regional  116 (19) 363 (22) 
Distant  16 (3) 36 (2) 
Unknown/ not applicable 122 (20) 323 (19) 
 Mean (SD) Mean (SD) 
Age at diagnosis  60·9 (11·6) 60·5 (11·6) 
Index of Relative Advantage 
and Disadvantage  
1025·6 (83·5) 1025·9 (81·7) 
Months between diagnosis and 
approach letter being sent to 
patient 
43·0 (11·4) 42·2 (11·2) 
a NSW and Victorian non-respondents only  
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Table 2. Demographic and clinical characteristics by language group 
Characteristic Arabic 
N = 57 
Chinese 
N = 141 
Greek 
N = 79 
Anglo-
Australian 
N = 319 
All 
immigrants 
p-value 
(Anglo-
Australians 
vs. 
immigrants) 
 n (%) n (%) n (%) n (%) n (%)  
Age at diagnosis (yrs)      
0·1 
18-49 10 (18) 21 (15) 5 (6) 33 (10) 36 (13) 
50-59 13 (23) 44 (31) 13 (16) 59 (19) 70 (25) 
60-69 20 (35) 39 (28) 29 (37) 122 (38) 88 (32) 
70+ 14 (25) 37 (26) 31 (39) 105 (33) 83 (30) 
Gender      
0·3 Male 30 (53) 70 (50) 49 (62) 157 (49) 149 (54) 
Female 27 (47) 71 (50) 30 (38) 162 (51) 128 (46) 
Marital status      
0·1 Married or partnered 43 (75) 120 (85) 59 (75) 237 (26) 222 (80) Not married or 
partnered 
14 (25) 21 (15) 20 (25) 82 (74) 55 (20) 
Education      
<0·0001 
Did not complete high 
school 
8 (14) 9 (6) 40 (51) 16 (5) 57 (21) 
High school/tech 
college 
26 (46) 61 (43) 31 (40) 229 (72) 118 (43) 
University 23 (40) 71 (50) 7 (9) 73 (23) 101 (37) 
Residence      
<0·0001 Major city 55 (100) 139 (99) 78(99) 274 (88) 271 (99)  
Regional and remote 0 (0) 1 (1) 1 (1) 38 (12) 2 (1) 
Religion      
0·3 Yes 55 (96) 70 (50) 78 (99) 246 (77) 203 (73) 
No 2 (4) 71 (50) 1 (1) 73 (23) 74 ()27 
Socio-economic status       
Low 4 (7) 5 (4) 7 (9) 15 (5) 16 (6) 
0·006 Med 37 (67) 93 (66) 49 (63) 240 (77) 179 (66) 
High 14 (25) 42 (30) 22 (28) 56 (18) 78 (29) 
Cancer type      
0·08 
Breast 21(37) 47 (33) 19 (24) 117 (37) 87 (31) 
Prostate 17 (30) 34 (24) 23 (29) 80 (25) 74 (27) 
Colorectal 8 (14) 28 (20) 16 (20) 53 (17) 52 (19) 
Bladder, kidney 3 (5) 5(4) 7 (9) 27(8) 15 (5) 
Leukaemia, 
lymphomas 
4 (7) 13(9) 6 (8) 22 (7) 23 (8) 
Head and neck 2 (4) 11 (8) 5 (6) 7 (2) 18 (7) 
Other  2 (4) 3 (2) 3 (4) 13 (4) 8 (3) 
Extent of disease at 
diagnosis 
     
0·9 
Localized  28(49) 79 (56) 52 (66) 183 (58) 159 (57) 
Regional  17 (30) 28 (20) 8 (10) 63 (20) 53 (19) 
Distant  0 (0) 6 (4) 1 (1) 9 (3) 7 (3) 
Unknown/ not 
applicable/missing 
12 (21) 28 (20) 18 (22) 64 (20) 58 (21) 
Current treatment      
0·1 No 50 (88) 131 (94) 72 (91) 302 (95) 253 (92) 
Yes 7 (12) 9 (6) 7 (9) 17 (5) 23 (8) 
       
 Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)  
Age at diagnosis 56·6 (10·8) 57·0 (10·9) 62·6 (10·4) 60·3 (10·5) 58·5 (11·0) 0·04 
 25 
Age 60·7 (10·8) 61·2 (11·0) 66·3 (10·4) 64·1 (10·7) 62·5 (11·0) 0·07 
Index of Relative 
Advantage and 
Disadvantage  
1019·7 
(86·2) 
1050·0 
(82·8) 
1031·1 
(88·9) 
1013·7 
(79·7) 
1038·5 
(85·9) 0·0003 
Years in Australia 26·9 (14·7) 23·7 (11·3) 44·7 (8·6) 63·8 (11·1) 30 (14·6) <0·0001 
Months since 
diagnosis  
43·2 (20·3) 47·4 (28·6) 44·6 (21·6) 42·9 (20·3) 45·8 (24·6) 0·1 
* Except for extent of disease, missing data rates ranged from 0-2%. 
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Table 3. Unadjusted means (standard deviations) of anxiety, depression and health-
related quality of life, and adjusteda mean differences (95% confidence intervals) 
between immigrants and Anglo-Australians.  
 Unadjusted mean 
(standard deviation) 
Adjusteda differences 
from Anglo-Australian 
(95% CI) 
p-valueb 
Anxietyc (R2 = 10·8)   0·04 
 Anglo-Australian 4·8 (3·9) Reference  
 Arabic 5·5 (4·4) 1·1 (-0·1, 2·2) 0·08 
 Chinese  4·7 (3·8) 0·07 (-0·8, 0·9) 0·9 
 Greek 5·6 (4·0) 1·4 (0·2, 2·7) 0·03 
    
Depressionc (R2 = 9·4)   <0·0001 
 Anglo-Australian 2·9 (2·9) Reference  
 Arabic 4·9 (4·2) 2·3 (1·3, 3·4) <0·0001 
 Chinese  4·4 (3·7) 1·7 (1·0, 2·4) <0·0001 
 Greek 4·6 (4·0) 2·0 (1·0, 3·0) <0·0001 
    
Quality of lifec (R2 = 6·4)   0·0002 
 Anglo-Australian 81·1 (14·3) Reference  
 Arabic 74·0 (18·6) -8·5 (-13·3, -3·7) 0·0005 
 Chinese  77·3 (14·1) -5·4 (-8·8. -2·0) 0·002 
 Greek 77·4 (15·4) -5·8 (-8·8, -2·0) 0·01 
a Adjusted for age, sex, education, married, SES, time since diagnosis, and type of cancer. The R2 is for 
the adjusted model. 
b The first p-value for each outcome is for the overall test of difference between culture groups from 
the adjusted models. The remaining three are for the test of immigrant group compared to Anglo-
Australians in the adjusted models.  
c Possible range for anxiety and depression 0-28; Possible range for QoL 0-100. 
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Table 4. Factors associated with anxiety, depression and health-related quality of life 
amongst immigrants. a  
 Anxiety 
(R2 = 13·6) 
 Depression 
(R2 = 7·2) 
 Quality of Life 
(R2 = 9·0) 
 
Variable Estimate 
(95% CI) 
p-
value 
Estimate 
(95% CI) 
p-
value 
Estimate 
(95% CI) 
p-
value 
Immigrant group  0·09  0·4  0·4 
 Greek 1·2 (-0·1, 2·6)  0·6 (-0·8, 2·0)  -1·0 (-6·9, 5·0)  
 Arabic  1·3 (-0·2, 2·7)  0·9 (-0·4, 2·2)  -3·7 (-9·2, 1·8)  
 Chinese Reference  Reference  Reference  
Confidence 
understanding 
English 
-0·3 (-1·5, 1·0) 0·7 -0·7 (-1·9, 
0·5) 
0·3 5·0 (-2·0, 8·6) 0·06 
Understanding 
health care system 
-0·5 (-1·7, 0·8) 0·4 -1·5 (-2·8, -
0·3) 
0·02 3·3 (-2·0, 8·6) 0·2 
Sex 0·9 (-0·7, 2·4) 0·3 -0·04 (-1·6, 
1·5) 
0·9 2·7 (-3·8, 9·1) 0·4 
Age 0·06 (-0·1, -
0·0006) 
0·05 0·0004 (-0·05, 
0·06) 
0·9 0·1 (0·3, -0·1) 0·3 
Married 0·6 (-0·7, 1·8) 0·4 0·4 (-0·9, 1·6) 0·5 0·2 (-5·1, 5·5) 0·9 
Socio-economic 
status 
·003 (-0·003, 
0·009) 
0·3 -0·001 (-
0·007, 0·004) 
0·7 0·005 (-0·02, 
0·03) 
0·7 
Education  0·1  0·09  0·05 
 Low -0·4 (-2·0, 1·1)  -0·9 (-2·5, 
0·6) 
 5·3 (-1·0, 11·6)  
 Med Reference  Reference  Reference  
 High -1·3 (-2·5, -0·09)  -1·2 (-2·3, -
0·01) 
 5·2 (0·2, 10·1)  
Cancer type  0·2  0·2  0·1 
 Breast Reference  Reference  Reference  
 Prostate -0·4 (-2·6, 1·6)  -1·0 (-3·0, 
1·1) 
 6·0 (-2·5, 14·6)  
 Colorectal -1·7 (-3·4, 0·06)  -1·3 (-3·0, 
0·4) 
 7·1 (0·1, 14·0)  
 Bladder, kidney 1·0 (-1·5, 3·5)  1·2 (-1·3, 3·7)  -4·8 (-14·9, 5·2)  
 Leukaemia, 
lymphomas 
0·2 (-2·0, 2·4)  1·1 (-1·1, 3·3)  -1·2 (-10·1, 7·8)  
 Head and neck -0·4 (-2·8, 2·0)  0·2 (-2·2, 2·5)  1·2 (-8·4, 10·8)  
 Other  1·2 (-2·1, 4·5)  1·1 (-2·2, 4·3)  -2·3 (-16·6, 12·1)  
Months since 
diagnosis 
-0·001 (-0·02, 
0·02) 
0·9 -0·008 (-0·03, 
0·01) 
0·5 0·05 (-0·03, 0·1) 0·2 
a Estimates are adjusted regression coefficients from three models (one for each outcome) which 
included all variables listed. 
 
 
